Condition
Congenital Adrenal Hyperplasia clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Congenital Adrenal Hyperplasia clinical trials that are recruiting, at sites in 20 countries (most in Italy (6), United States (5), Argentina (4)). By phase: Phase 2 (2), Phase 4 (1), Phase 2/3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 20Countries
Newest Congenital Adrenal Hyperplasia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Crinecerfont safety testing in babies with classic CAH under 4 years old | Phase 2 | San Francisco, California and 10 other locations | Recruiting | Apr 17, 2026 |
| Atumelnant for children with classic congenital adrenal hyperplasia (Balance-CAH) | Phase 2/3 | Los Angeles, California and 52 other locations | Recruiting | Sep 8, 2025 |
| Atumelnant for adults with classic congenital adrenal hyperplasia | Phase 3 | Los Angeles, California and 81 other locations | Recruiting | Aug 27, 2025 |
| Registry for male patients with congenital adrenal hyperplasia | — | Bologna | Recruiting | Dec 31, 2024 |
| Long-term evaluation of atumelnant for congenital adrenal hyperplasia | Phase 2 | Minneapolis, Minnesota and 12 other locations | Recruiting | Dec 2, 2024 |
| Registry for Rare Diseases | — | Buenos Aires, Buenos Aires | Recruiting | Aug 27, 2024 |
| Evaluating Lu AG13909 for treating congenital adrenal hyperplasia | Phase 1/2 | Ann Arbor, Michigan and 16 other locations | Recruiting | Jan 3, 2023 |
| Observing the health management of patients with rare genetic syndromes | — | Rotterdam, South Holland | Recruiting | Jul 9, 2020 |
| Once-daily dual-release hydrocortisone for adults with congenital adrenal hyperplasia | Phase 4 | Naples | Recruiting | Nov 30, 2018 |
All recruiting trials (9)
-
Crinecerfont safety testing in babies with classic CAH under 4 years old
This study tests whether crinecerfont is safe and tolerable in children under 4 years with classic CAH who have been on hydrocortisone.
-
Atumelnant for children with classic congenital adrenal hyperplasia (Balance-CAH)
This study will test whether atumelnant is safe and helps control hormone levels in children aged 1 to under 18 with classic congenital adrenal hyperplasia.
-
Atumelnant for adults with classic congenital adrenal hyperplasia
This will test whether taking once-daily atumelnant helps adults with classic 21‑hydroxylase deficiency CAH who are already on stable glucocorticoid therapy.
-
Registry for male patients with congenital adrenal hyperplasia
This study is creating a registry for boys with congenital adrenal hyperplasia to better understand the condition and track how common it is in the Emilia Romagna region.
-
Long-term evaluation of atumelnant for congenital adrenal hyperplasia
This study is testing if a new treatment called atumelnant is safe and effective for people with congenital adrenal hyperplasia who have already participated in a related study.
-
Registry for Rare Diseases
This study is creating a detailed registry to collect information on rare diseases like amyloidosis and sarcoidosis to help improve how they are diagnosed and treated.
-
Evaluating Lu AG13909 for treating congenital adrenal hyperplasia
This study is testing different doses of a new medication called Lu AG13909 to see if it can safely help adults with congenital adrenal hyperplasia manage their hormone levels better.
-
Observing the health management of patients with rare genetic syndromes
This study looks at how patients with rare genetic syndromes like Prader-Willi and Klinefelter manage their health as they move from children's care to adult care to see what support they need.
-
Once-daily dual-release hydrocortisone for adults with congenital adrenal hyperplasia
This will test whether a once-daily dual-release hydrocortisone controls hormones, metabolic effects, and quality of life better than conventional multiple-dose glucocorticoids in adults with 21-hydroxylase congenital adrenal hyperplasia.
Related topics
Quick answers
How many Congenital Adrenal Hyperplasia clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 20 countries. The most sites are in Italy (6 trials), United States (5 trials), Argentina (4 trials), United Kingdom (4 trials), Brazil (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 4: 1, Phase 2/3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.